Kim Julie So-Young — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Kim Julie So-Young has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Profile
Kim Julie So-Young is a prominent business executive known for her role in the pharmaceutical industry. As of April 2026, she has been appointed as the CEO-Elect of Takeda Pharmaceutical Co. Ltd, a leading global biopharmaceutical company based in Japan. Her leadership is anticipated to guide the company through its next phase of growth and innovation in the healthcare sector.
Role
President and CEO, Director
Notability
75/100
Board memberships
Takeda Pharmaceutical Co. Ltd
Awards & honors
Appointed CEO - Elect of Takeda Pharmaceutical Co. Ltd
Kim Julie So-Young is a prominent business executive known for her role in the pharmaceutical industry. As of April 2026, she has been appointed as the CEO-Elect of Takeda Pharmaceutical Co. Ltd, a leading global biopharmaceutical company based in Japan. Her leadership is anticipated to guide the company through its next phase of growth and innovation in the healthcare sector.…
How many SEC Form 4 filings has Kim Julie So-Young submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Kim Julie So-Young's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
